Development Projects

Articles

Aquadro C, Konway C, Wolf B, Anfray C, Hareendran A, Mear I, Nadjar A. Development of a standardized classification system for the translations of Patient-Reported Outcome (PRO) measures. Quality of Life Newsletter. 2008; 39, p5.

Carbonnel H, Longin J, Lobo-Luppi L. Acquadro C. Use of Patient-Reported Outcomes in Gene Therapy Clinical Trials. Quality of Life Newsletter. 2003; 30, p20-22

Manificat S, Dazord A, Mechoud J, Rodrigues C, Bouttier M, Conway K. School integration for disabled children: a quality of life study. Quality of Life Newsletter. 2002; 28(January-August), p16

Manificat S, Dazord A, Langue L, Danjou G, Escoffier Ch, Gerbay A, Dudognon P, Morin I, Milongo L, Payot F, Raiz AM, Simon-Ghedriri MJ, Stagnara J. Impact du mode d’allaitement du nourrisson sur la qualité de Vie de la mère et la qualité de vie de l’enfant: résultats d’une étude pilote. Le Pédiatre. 2000;Tome XXXVI (1), p17-23.

Manificat S, Dazord A, Langue J, Danjou G, Bauche P, Bovet F, Cubell JM, Luchelli R, Tockert E, Conway K. A new intrument to evaluate infant quality of life. Quality of Newsletter. 1999; 23(Sept-Dec), p7-8.

Spertus J, Patrick Green C, Conway K, Uzun V. Creating a New Disease-Specific Health Measure for Congestive Heart Failure: a Prototype for Instrument Development in the Current Era. Quality of Life Newsletter. 1998; 20(Sept-Dec), p9-10.

Workshops

Conway K, Manificat S. Dazord A. Infant QoL: a new instrument. Presented at the 6th Annual Symposium of Contributed Papers on QoL Evaluation, Drug Information Association, Hilton Head – USA, March 1999.

Oral presentations

Manificat S, Dazord A, Conway K, Chevallet L, Emery MP, Langue L, Danjou G. Infant Quality of Life: a new instrument. Presented at the 6th annual symposium of contributed papers on QoL evaluation, Drug Information Association, Hilton Head – USA, March 1999.

Posters

Mouchet J, Emery MP, Maier W. Development of a Post-Marketing Requirements (PMR) Database. Presented at the ISPOR 15th Annual European Congress, Berlin, Germany, November 2012.

Mouchet J, Albrieux M, Maier W. Development of a regulatory post-marketing studies database. Presented at the ISPOR 17th Annual International Meeting, Washington DC, USA, June 2012.

Caron M, Mouchet J, Emery MP, Longin J, Maier W. Development of a regulatory post-marketing studies database. Presented at the International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Rhode Island – USA, August 2009.

Caron M, Mouchet J, Emery MP, Longin J, Maier W. Development of a regulatory post-marketing studies database. Presented at the 14th Annual International Meeting of the ISPOR, Orlando – USA, May 2009.

Conway K, Mear I. Rationale for the Development of a Classification System for the Translations of PRO Instruments. Presented at the 15th Annual Conference of the International Society for Quality Of Life Research (ISOQOL), Montevideo – Uruguay, October 2008.

Aquadro C, Konway C, Wolf B, Anfray C, Hareendran A, Mear I, Nadjar A. Development of a standardized classification system for the translations of Patient-Reported Outcome (PRO) measures. Presented at the 13th Annual International Meeting (ISPOR), Toronto – Ontario, Canada, May 3-7, 2008.

Duracinsky M, Cervoni J, Vincent V, LAscoux C, Bourgarit A, Acquadro C, Conway K, Wu, A, Chassany O. Validation d’un questionnaire de qualité de vie spécifique de la lipodystrophie liée à la pathologie VIH. La Revue de Médecine Interne, 2004; 25(Supp 1), p189.

Girod I, Keininger DL, de la Loge C, Hunter M. Presentation of the 23-item Women’s Health Questionnaire (WHQ): scoring and interpretation issues. Value in Health. 2000; 3(5), p341-342. Presented at the 3 rd Annual European Meeting, International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Antwerp – Belgium, November 2000.

Girod I, Keininger DL, de la Loge C, Hunter M. Methodological issues in evaluating conceptual equivalence: applications of the Women’s Health Questionnaire. Value in Health. 2000; 3(5), p342. Presented at the 3rd Annual European Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Antwerp – Belgium, November 2000.

Girod I, Keininger DL, de la Loge C, Hunter M. Presentation of the 23-item Women’s Health Questionnaire (WHQ): scoring and interpretation issues. Quality of Life Research. 2000; 9(3), p25. Presented at the 7th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Vancouver – Canada, October 2000.

Girod I, Keininger DL, de la Loge C, Hunter M. Methodological issues in evaluating conceptual equivalence: applications of the Women’s Health Questionnaire. Quality of Life Research. 2000; 9(3), p25. Presented at the 7th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Vancouver – Canada, October 2000.

Girod I, Keininger DL; de la Loge C, Hunter M. Development of a new scoring of the Women’s Health Questionnaire (WHQ). Value in Health. 2000; 3(2), p103. Presented at the 5th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Crystal City – USA, May 2000.

Girod I, Adesina A, Keininger DL, , Wool C, Marquis P. Implications of menopausal symptoms on quality of life. Value in Health. 1999; 2(3), p209. Presented at the 4th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Crystal City – USA, May 1999.

Keininger DL, Abetz L, Girod I, Adesina A, Dubois D, Wool C, Marquis P. Comparison of Quality of Life between Menopausal women and age-matched peers. Value in Health. 1999; 2(3), p210. Presented at the 4th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Crystal City – USA, May 1999.